Basilea reports publication of clinical data for anticancer drug candidates BAL101553 in glioblastoma and derazantinib in intrahepatic cholangiocarcinoma at ASCO meeting

NEXT STORY
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials
PREV STORY
Xolair® (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference

author_avatar
NASDAQ Market News

PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability

DELRAY BEACH, Fla., Dec. 06, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life ...

author_avatar
NASDAQ Market News

VBI Vaccines Appoints Blaine McKee to Board of Directors

CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), ...

author_avatar
NASDAQ Market News